Product Information
ATOVAQUONE 750 MG/5 ML SUSP is a generic product labeled by NorthStar Rx LLC, priced at $0.7561 per ML under NDC 72603024801. Its NADAC has been published 107 times since Aug 7, 2024.
FDA first approved this application on Oct 11, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/5mL
Manufacturer
NorthStar Rx LLCNDC
72603024801
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATOVAQUONEApproval Type
Generic (ANDA)
FDA Application
ANDA210692FDA Approved
10/11/2018
TE Code
AB
On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE 750 MG/5 ML SUSP has been published 107 times since Aug 7, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7561 per ML |
|---|---|
| All-time high | $1.0086 (Sep 11, 2024) |
| All-time low | $0.6842 (Jul 22, 2026) |
| 52-week high | $0.8766 |
| 52-week low | $0.6842 |
| Median price | $0.8344 |
| Average price | $0.8096 |
| Largest weekly change | +33.9% (Aug 21, 2024) |
| Weeks tracked | 107 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATOVAQUONE 750 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE 750 MG/5 ML SUSP, manufactured by NorthStar Rx LLC, is $0.7561 per ML (NDC 72603024801), effective Aug 19, 2026.
How has the price of ATOVAQUONE 750 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 107 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE 750 MG/5 ML SUSP?
Since Aug 7, 2024, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has ranged from a low of $0.6842 (Jul 22, 2026) to a high of $1.0086 (Sep 11, 2024), with a median of $0.8344 per ML.
Are there cheaper alternatives to ATOVAQUONE 750 MG/5 ML SUSP?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATOVAQUONE 750 MG/5 ML SUSPENSION CUP, is $0.7418 per ML — about 2% below ATOVAQUONE 750 MG/5 ML SUSP.
Who manufactures ATOVAQUONE 750 MG/5 ML SUSP?
ATOVAQUONE 750 MG/5 ML SUSP (NDC 72603024801) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.